Celtic Staffs Up

Bob Milsted and Solomon Babani have joined Celtic Pharmaceutical Holdings, a global private equity firm focused on the biotech and pharma markets. Milsted will serve as a managing director and head of European development, having previously been with AstraZeneca as vice president of global regulatory affairs for oncology and infection. Banai will serve as director of contracts and vendor management, and previously was associate director in the CRO management group of Novartis Pharmaceuticals. www.celticpharma.com